Innovative therapeutics

Investors

Leadership Team

Under the leadership of Chairman and Chief Executive Officer, Mr. Jean-Jacques Bienaimé, BioMarin’s executive management team includes accomplished leaders with deep and broad executive experience. Supported by a staff of approximately 2,200 employees worldwide, BioMarin is focused on delivering first-in-class and best-in-class therapeutics to patients with rare genetic diseases.

Chairman and Chief Executive Officer

Executive Vice President,
Technical Operations

President, Worldwide Research & Development

Executive Vice President and Chief Financial Officer

Executive Vice President and Chief Commercial Officer

Executive Vice President, Human Resources and Corporate Affairs

Senior Vice President, Product Development

Senior Vice President, Business & Corporate Development

Senior Vice President, Chief Compliance Officer

Vice President Information Technology, Chief Information Officer

Executive Vice President and General Counsel


BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information